Plasma Adipokines and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus–Infected Carriers: A Prospective Study in Taiwan
Chi‐Ling Chen(National Taiwan University Hospital), Chien‐Jen Chen(Academia Sinica), Chuen-Fei Chen(National Taiwan University), Hwai‐I Yang(Chang Gung University), Wei‐Shiung Yang(National Taiwan University), Pei‐Jer Chen(National Taiwan University), San‐Lin You(National Taiwan University), Jia‐Horng Kao(National Taiwan University Hospital), Chun‐Jen Liu(National Taiwan University), Li‐Yu Wang(Mackay Medical University), Ding‐Shinn Chen(Nanyang Institute of Technology), Sheng‐Nan Lu(Chang Gung University)
Cited by 26
Related Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
|Gastroenterology|2006|1.5k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k